Matthew Smeds, MD
Vascular Surgery · Saint Louis, MONPI 1003067240
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,176 of the $13,547 with a category attached, or 89.9%. It is spread thinly across 28 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,158 and has fallen 64.5% since, to $1,122 in 2025.
Across 165 payments — averaging $82.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$3K
- W. L. Gore & Associates, Inc.$3K
- Penumbra, Inc.$2K
- Medtronic$1K
- Bolton Medical Inc$973
- Getinge USA Sales, LLC$763
- plus $4K from 22 others
Across 12 payments — averaging $2079.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$14K
- Merit Medical Systems Inc$4K
- Bolton Medical Inc$4K
- W. L. Gore & Associates, Inc.$2K
What the payments were for
- Travel & lodging$1,1398%
- Food & beverage$12,17690%
- Entertainment$2322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 22 | $2,675 |
| W. L. Gore & Associates, Inc. | 26 | $2,608 |
| Penumbra, Inc. | 20 | $1,939 |
| Medtronic(2 entities) | 8 | $1,023 |
| Bolton Medical Inc | 10 | $973 |
| Getinge USA Sales, LLC | 21 | $763 |
| Bard Peripheral Vascular, Inc. | 14 | $652 |
| Inari Medical, Inc. | 3 | $531 |
| Abbott | 7 | $434 |
| Veryan Medical Incorporated | 1 | $220 |
| Acell, Inc. | 2 | $215 |
| Philips North America LLC | 4 | $200 |
| Cook Medical LLC | 3 | $163 |
| Edwards Lifesciences | 1 | $147 |
| Innocoll Pharmaceuticals Limited | 1 | $142 |
| Kerecis Limited | 4 | $141 |
| Baxter Healthcare | 2 | $138 |
| Artivion, Inc. | 2 | $113 |
| Shockwave Medical, Inc | 1 | $100 |
| Johnson & Johnson | 1 | $88 |
| Angiodynamics, Inc. | 4 | $85 |
| Tactile Systems Technology Inc | 1 | $79 |
| Shape Memory Medical Inc. | 1 | $33 |
| Access Pro Medical, LLC | 1 | $24 |
| Sanara Medtech Inc. | 1 | $21 |
| Medical Device Business Services, Inc. | 1 | $20 |
| ETS Wound Care LLC | 2 | $17 |
| Cvrx, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$2,813
- ENROUTE Transcarotid Stent$1,853
- ENHANCE Transcarotid Peripheral Access Kit$931
- Indigo System$868
- GORE EXCLUDER AAA Endoprosthesis$590
- Indigo$576
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$544
- ENROUTE Transcarotid Stent System$506
- ENROUTE 0.014 Guidewire$506
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$454
- ENROUTE .014 Guidewire$425
- Valiant Captivia$411
- Perclose ProGlide suture mediated closure system$350
- TREO ABDOMINAL STENT-GRAFT SYSTEM$323
- FlowTriever$295
- ClotTriever$295
- Grafts$285
- HawkOne$263
- FLOWTRIEVER CATHETER, S$235
- CT THROMBECTOMY SYSTEM KIT$235
How this compares
$13,547 in reported general payments places this provider in the 70th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $10,564 |
| Cilostazol | 35 | $1,009 |
| Gabapentin | 26 | $213 |
| ClopidogrelClopidogrel Bisulfate | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $88 | $10,56411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 92 vascular surgery providers in Missouri.
Other vascular surgery in Saint Louis
- Jeffrey JimSaint Louis$1.2M
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Patrick GeraghtySaint Louis$65K
- Nathan DrozSaint Louis$38K
- Mohamed ZayedSaint Louis$30K
- Vipul KhetarpaulSaint Louis$23K
- Zachary WankenSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.